Provided by Tiger Trade Technology Pte. Ltd.

Mizuho

11.45
+0.39003.53%
Post-market: 11.42-0.0251-0.22%19:30 EDT
Volume:4.05M
Turnover:46.31M
Market Cap:139.61B
PE:16.61
High:11.49
Open:11.34
Low:11.34
Close:11.06
52wk High:11.49
52wk Low:6.09
Shares:12.19B
Float Shares:11.07B
Volume Ratio:1.22
T/O Rate:0.04%
Dividend:0.19
Dividend Rate:1.65%
EPS(TTM):0.6892
EPS(LYR):0.6326
ROE:12.49%
ROA:0.48%
PB:1.86
PE(LYR):18.10

Loading ...

Mizuho Securities Adjusts Entergy Price Target to $121 From $122, Maintains Outperform Rating

MT Newswires Live
·
Jul 30

Mizuho Adjusts Price Target on Vertiv to $300 From $380, Maintains Outperform Rating

MT Newswires Live
·
Jul 30

Mizuho Lifts Price Target on Air Products & Chemicals to $355 From $345, Keeps Outperform Rating

MT Newswires Live
·
Jul 30

Mizuho Financial Gr Q1 EPS $0.22 Up From $0.15 YoY, Sales $15.818B Up From $14.736B YoY

Benzinga Earnings
·
Jul 30

Mizuho Financial Group Doubles Share Buyback Program to 200 Billion Yen

MT Newswires Live
·
Jul 30

Mizuho Financial Group's Profit Soars 46% in Fiscal Q1

MT Newswires Live
·
Jul 30

Mizuho Leasing Injects ¥1.08 Billion Into Restricted Stock Benefit Trust

TIPRANKS
·
Jul 30

Mizuho Leasing Delivers Profit Surge in First Quarter, Confirms Full-Year Outlook and Dividend Plan

TIPRANKS
·
Jul 30

Mizuho Doubles Share Buyback to ¥200 Billion and Extends Cancellation Timeline

TIPRANKS
·
Jul 30

Mizuho lifts full-year profit outlook after robust Q1 earnings

TIPRANKS
·
Jul 30

Mizuho Leasing 1Q Net Y23.26b vs Net Y15.22b

Dow Jones
·
Jul 30

Skyworks is Maintained at Underperform by Mizuho

Dow Jones
·
Jul 30

Coupang is Maintained at Neutral by Mizuho

Dow Jones
·
Jul 29

Brown & Brown is Maintained at Outperform by Mizuho

Dow Jones
·
Jul 29

Mizuho Securities Adjusts CMS Energy Price Target to $77 From $78, Maintains Neutral Rating

MT Newswires Live
·
Jul 29

Mizuho Securities Adjusts NXP Semiconductors Price Target to $190 From $200, Maintains Underperform Rating

MT Newswires Live
·
Jul 29

Mizuho Raises Price Target on EyePoint Pharmaceuticals to $39 From $36, Keeps Outperform Rating

MT Newswires Live
·
Jul 29

EyePoint Pharmaceuticals (EYPT) Gets a Buy from Mizuho Securities

TIPRANKS
·
Jul 29

Mizuho Securities Upgrades Lineage to Outperform From Neutral, Raises Price Target to $47 From $40

MT Newswires Live
·
Jul 29

Mizuho Adjusts Price Target on Xylem to $130 From $124, Maintains Neutral Rating

MT Newswires Live
·
Jul 29